New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2016, Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach
View latest version (2016)Bibliographic Info
GuidelineAntiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings : towards universal access : recommendations for a public health approach
Year of Publication2006
Issuing InstitutionWorld Health Organization
Recommendation
Status
Retired
Recommended in favor
Strong
Certainty of evidence
Moderate
If stavudine (d4T) or zidovudine (AZT) has been used in first-line therapy, use tenofovir disoproxil fumarate (TDF) + (3TC) or emtricitabine (FTC) as the nucleoside reverse transcriptase inhibitor (NRTI) backbone in second- line therapy